Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — Novonesis A S — Q3 2024 Earnings Presentation
13 slides from Novonesis A/s Class B's earnings presentation, Nov 7, 2024
Slide 1: Conference call 9M 2024
Conference call 9M 2024
Slide 2: Forward-looking statement
Forward-looking statement Disclaimer This announcement includes forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the control of the combined group and all of which are based on the combined group's current belief
Slide 3: 9M organic sales growth of 9% (11% in Q3)
9M organic sales growth of 9% (11% in Q3). 2024 organic Sales and organic sales growth y/y 45% 55% sales growth now expected at upper end of 7-8% range Food & Health Biosolutions Planetary Health EURm Biosolutions Sales performance 9M 2024 • Organic sales growth (OSG) of 9% +9% • Growth driven by vo
Slide 4: Food & Health Biosolutions
Human Health Sales and organic sales growth, 26% Food & Health Biosolutions y/y Food & Health Biosolutions 74% EURm +8% Food & Beverages OSG Sales performance 9M 2024 • Organic sales growth of 8% +11% OSG • Growth supported by both Food & Beverages and Human 1,296.1 1,337.1 Health 436.4 461.6 9M 202
Slide 5: Food & Health Biosolutions: Food & Beverages
Sales and organic sales growth Food & Health Biosolutions: Food & Beverages y/y Food & Beverages EURm +9% OSG Sales performance 9M 2024 +11% • Organic sales growth of 9% OSG 960.7 991.5 • Strong performance in Dairy and solid development in Baking • Innovation and penetration key drivers of growth 3
Slide 6: Food & Health Biosolutions: Human Health
Sales and organic sales growth Human Health y/y Food & Health Biosolutions: Human Health EURm +3% OSG Sales performance 9M 2024 +11% • Organic sales growth of 3% OSG 335.4 345.6 • Strong sales of Advanced Protein Solution to anchor customer • Growth impacted by strong comparable and timing in HMO an
Slide 7: Planetary Health Biosolutions
Household Care Sales and organic sales growth 35% Planetary Health Biosolutions y/y Planetary Health Biosolutions 65% EURm Agriculture, +9% Energy & Tech OSG Sales performance 9M 2024 • Organic sales growth of 9% +12% OSG • Growth driven by Household Care, supported by Agriculture, 1,505.1 1,627.0 E
Slide 8: Planetary Health Biosolutions: Household Care
Sales and organic sales growth Household Care y/y Planetary Health Biosolutions: Household Care EURm Sales performance 9M 2024 +15% OSG • Organic growth of 15%, with double-digit growth across all +13% regions driven by increased penetration, innovation, and OSG pricing, supported by timing 507,9 57
Slide 9: Planetary Health Biosolutions: Agriculture, Energy & Tech
Sales and organic sales growth Agriculture, Energy & Tech y/y Planetary Health Biosolutions: Agriculture, Energy & Tech EURm +7% OSG Sales performance 9M 2024 • Organic growth of 7%, driven by double-digit growth in Energy, +12% OSG supported by solid growth in Tech 997.2 1,049.7 • Growth impacted b
Slide 10: Outlook 2024
Outlook 2024 • Organic sales growth now at upper end of 7-8% range, driven predominately by volumes • Adjusted EBITDA margin confirmed between 35.5-36.5% Outlook 2024¹ Organic sales growth at upper end of 7-8% Adjusted EBITDA margin 35.5-36.5% For modeling purposes: Special items* EURm ~190* Net fin
Slide 11: Summary
Summary • Strong broad-based 9M performance • H2 growth acceleration vs. H1 including positive timing in Q3 • Full-year organic sales growth outlook at upper end of range • Strong traction on integration activities including cost synergies • Sales synergies confirmed to materialize from 2025 and onw
Slide 12: Q&A
Slide 13: Organic sales performance by region
Organic sales performance by region North America Developed markets 9M y/y: +4% 9M y/y: +6% Europe, the Middle East & Africa 9M y/y: +8% 65% 33% of sales of sales 36% of sales Asia Pacific Latin America 9M y/y: +13% Emerging markets 9M y/y: +14% 9M y/y: +14% 12% 19% 35% of sales of sales of sales 13